The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Catherine Price: “Vitamania”

Thursday, Feb 26 2015Tens of millions of Americans take nutritional supplements. New studies allege some pills do not contain what is on the label. Other research indicates consumers may be ingesting too many vitamins. New concerns about dietary supplements.

New Research On Preventing Peanut Allergies

Wednesday, Feb 25 2015The number of children allergic to peanuts has skyrocketed. A new study suggests doctors have been giving the wrong advice about peanuts for years. A discussion of what the latest research says about preventing the sometimes life-threatening allergy.